ELF5 isoform expression is tissue-specific and significantly altered in cancer.
about
The innate and adaptive infiltrating immune systems as targets for breast cancer immunotherapy.EWSR1/ELF5 induces acute myeloid leukemia by inhibiting p53/p21 pathway.Comprehensive landscape of subtype-specific coding and non-coding RNA transcripts in breast cancer.Variant 2 of KIAA0101, antagonizing its oncogenic variant 1, might be a potential therapeutic strategy in hepatocellular carcinoma.ELF3, ELF5, EHF and SPDEF Transcription Factors in Tissue Homeostasis and Cancer
P2860
ELF5 isoform expression is tissue-specific and significantly altered in cancer.
description
2016 nî lūn-bûn
@nan
2016 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2016 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
ELF5 isoform expression is tissue-specific and significantly altered in cancer.
@ast
ELF5 isoform expression is tissue-specific and significantly altered in cancer.
@en
type
label
ELF5 isoform expression is tissue-specific and significantly altered in cancer.
@ast
ELF5 isoform expression is tissue-specific and significantly altered in cancer.
@en
prefLabel
ELF5 isoform expression is tissue-specific and significantly altered in cancer.
@ast
ELF5 isoform expression is tissue-specific and significantly altered in cancer.
@en
P2093
P2860
P50
P1476
ELF5 isoform expression is tissue-specific and significantly altered in cancer.
@en
P2093
Christopher J Ormandy
Daniel L Roden
David Gallego-Ortega
P2860
P2888
P356
10.1186/S13058-015-0666-0
P577
2016-01-07T00:00:00Z
P5875
P6179
1023071342